Share
Market Research Report

PERSONALIZED NUTRITION MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Product TypePersonalized Dietary Supplements (vitamins, probiotics) · Nutraceuticals · Medical Foods (Pharmaceutical-grade, disease-specific, requires a prescription) · and Software and Digital Platforms
  • By ApplicationStandard Supplements (General wellness and vitality, Weight management and metabolism support, Muscle recovery, Immune system enhancement, Energy and stress management, Cognitive and mental performance) · and Disease-Based Formulations
  • By TechnologyGenetic Testing · Microbiome and Gut Health Analysis · Blood Biomarker and Metabolic Testing · and Others
  • By Dosage FormCapsules and Tablets · Powders and Mixes · and Others (Liquid, etc.)
  • By Age GroupPediatric · Adult · and Geriatric
  • By End UserIndividuals/Consumers · Hospitals and clinics · Nutritionists and dietitians · Home Care Settings · Corporate wellness programs · and Research and Academic Institutes
  • By Distribution ChannelOnline and Offline
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In17 Mar 2026
  • Report CodeCMI8721
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Market Segmentation

  •  Product Type Insights (Revenue, USD Bn, 2021 - 2033)

    • Personalized Dietary Supplements (vitamins, probiotics)
    • Nutraceuticals
    • Medical Foods (Pharmaceutical-grade, disease-specific, requires a prescription)
    • Software and Digital Platforms
  •  Application Insights (Revenue, USD Bn, 2021 - 2033)

    • Standard Supplements
      • General wellness and vitality
      • Weight management and metabolism support
      • Muscle recovery
      • Immune system enhancement
      • Energy and stress management
      • Cognitive and mental performance
    • Disease-Based Formulations
      • Metabolic Disorders
      • Gastrointestinal (GI) Disorders
      • Cardiometabolic Disorders
      • Oncology Support
      • Renal and Hepatic Disorders
      • Other Chronic Disease Management
  •  Technology Insights (Revenue, USD Bn, 2021 - 2033)

    • Genetic Testing
    • Microbiome and Gut Health Analysis
    • Blood Biomarker and Metabolic Testing
    • Others
  •  Dosage Form Insights (Revenue, USD Bn, 2021 - 2033)

    • Capsules and Tablets
    • Powders and Mixes
    • Others (Liquid, etc.)
  •  Age Group Insights (Revenue, USD Bn, 2021 - 2033)

    • Pediatric
    • Adult
    • Geriatric
  •  End User Insights (Revenue, USD Bn, 2021 - 2033)

    • Individuals/Consumers
    • Hospitals and clinics
    • Nutritionists and dietitians
    • Home Care Settings
    • Corporate wellness programs
    • Research and Academic Institutes
  •  Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)

    • Online
    • Offline
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa